Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ GNPAT Monoclonal Antibody (OTI1E7)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA527400

Catalog No. PIMA527400


Only null left
Add to Cart

Description

Description

GNPAT Monoclonal Antibody for Western Blot, IHC (P)

GNPAT is a key enzyme located in the peroxisomal membrane which is essential to the synthesis of ether phospholipids. Mutations in GNPAT are associated with rhizomelic chondrodysplasia punctata type 2, which is characterized by rhizomelic shortening of femur and humerus, vertebral disorders, cataract, cutaneous lesions and severe mental retardation.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

GNPAT
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3
O15228
GNPAT
Full length human recombinant protein of GNPAT produced in E.coli.
100 μL
Primary
Human
Antibody
IgG1
Immunohistochemistry (Paraffin), Western Blot
OTI1E7
Unconjugated
GNPAT
acyl-CoA:dihydroxyacetonephosphate acyltransferase; acyl-CoA:dihydroxyacetonephosphateacyltransferase; AU019525; D1Ertd819e; DAPAT; DAP-AT; DHAPAT; DHAP-AT; Dihydroxyacetone phosphate acyltransferase; glycerone-phosphate O-acyltransferase; glyceronephosphate O-acyltransferase; GNPAT; RCDP2
Mouse
Affinity chromatography
RUO
8443
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.